Functional Near Infrared Optical Brain Imaging System (fNIRS)
Functional Near Infrared Optical Brain Imaging System (fNIRS) market is segmented by players, reg ... Read More
Global Ion Channel Modulators Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ion Channel Modulators Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Channel Blockers
1.2.3 Channel Openers
1.3 Market by Application
1.3.1 Global Ion Channel Modulators Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Clinical Trials
1.3.3 Hospital
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ion Channel Modulators Market Perspective (2017-2028)
2.2 Ion Channel Modulators Growth Trends by Region
2.2.1 Ion Channel Modulators Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Ion Channel Modulators Historic Market Size by Region (2017-2022)
2.2.3 Ion Channel Modulators Forecasted Market Size by Region (2023-2028)
2.3 Ion Channel Modulators Market Dynamics
2.3.1 Ion Channel Modulators Industry Trends
2.3.2 Ion Channel Modulators Market Drivers
2.3.3 Ion Channel Modulators Market Challenges
2.3.4 Ion Channel Modulators Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ion Channel Modulators Players by Revenue
3.1.1 Global Top Ion Channel Modulators Players by Revenue (2017-2022)
3.1.2 Global Ion Channel Modulators Revenue Market Share by Players (2017-2022)
3.2 Global Ion Channel Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Ion Channel Modulators Revenue
3.4 Global Ion Channel Modulators Market Concentration Ratio
3.4.1 Global Ion Channel Modulators Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ion Channel Modulators Revenue in 2021
3.5 Ion Channel Modulators Key Players Head office and Area Served
3.6 Key Players Ion Channel Modulators Product Solution and Service
3.7 Date of Enter into Ion Channel Modulators Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ion Channel Modulators Breakdown Data by Type
4.1 Global Ion Channel Modulators Historic Market Size by Type (2017-2022)
4.2 Global Ion Channel Modulators Forecasted Market Size by Type (2023-2028)
5 Ion Channel Modulators Breakdown Data by Application
5.1 Global Ion Channel Modulators Historic Market Size by Application (2017-2022)
5.2 Global Ion Channel Modulators Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Ion Channel Modulators Market Size (2017-2028)
6.2 North America Ion Channel Modulators Market Size by Country (2017-2022)
6.3 North America Ion Channel Modulators Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Ion Channel Modulators Market Size (2017-2028)
7.2 Europe Ion Channel Modulators Market Size by Country (2017-2022)
7.3 Europe Ion Channel Modulators Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Ion Channel Modulators Market Size (2017-2028)
8.2 Asia-Pacific Ion Channel Modulators Market Size by Country (2017-2022)
8.3 Asia-Pacific Ion Channel Modulators Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Ion Channel Modulators Market Size (2017-2028)
9.2 Latin America Ion Channel Modulators Market Size by Country (2017-2022)
9.3 Latin America Ion Channel Modulators Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ion Channel Modulators Market Size (2017-2028)
10.2 Middle East & Africa Ion Channel Modulators Market Size by Country (2017-2022)
10.3 Middle East & Africa Ion Channel Modulators Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.(US)
11.1.1 Pfizer, Inc.(US) Company Detail
11.1.2 Pfizer, Inc.(US) Business Overview
11.1.3 Pfizer, Inc.(US) Ion Channel Modulators Introduction
11.1.4 Pfizer, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022)
11.1.5 Pfizer, Inc.(US) Recent Development
11.2 Neusentis, Inc.(US)
11.2.1 Neusentis, Inc.(US) Company Detail
11.2.2 Neusentis, Inc.(US) Business Overview
11.2.3 Neusentis, Inc.(US) Ion Channel Modulators Introduction
11.2.4 Neusentis, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022)
11.2.5 Neusentis, Inc.(US) Recent Development
11.3 AstraZeneca(UK)
11.3.1 AstraZeneca(UK) Company Detail
11.3.2 AstraZeneca(UK) Business Overview
11.3.3 AstraZeneca(UK) Ion Channel Modulators Introduction
11.3.4 AstraZeneca(UK) Revenue in Ion Channel Modulators Business (2017-2022)
11.3.5 AstraZeneca(UK) Recent Development
11.4 Aurora Biomed, Inc.(Canada)
11.4.1 Aurora Biomed, Inc.(Canada) Company Detail
11.4.2 Aurora Biomed, Inc.(Canada) Business Overview
11.4.3 Aurora Biomed, Inc.(Canada) Ion Channel Modulators Introduction
11.4.4 Aurora Biomed, Inc.(Canada) Revenue in Ion Channel Modulators Business (2017-2022)
11.4.5 Aurora Biomed, Inc.(Canada) Recent Development
11.5 CalciMedica, Inc.(US)
11.5.1 CalciMedica, Inc.(US) Company Detail
11.5.2 CalciMedica, Inc.(US) Business Overview
11.5.3 CalciMedica, Inc.(US) Ion Channel Modulators Introduction
11.5.4 CalciMedica, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022)
11.5.5 CalciMedica, Inc.(US) Recent Development
11.6 Cellectricon AB(Sweden)
11.6.1 Cellectricon AB(Sweden) Company Detail
11.6.2 Cellectricon AB(Sweden) Business Overview
11.6.3 Cellectricon AB(Sweden) Ion Channel Modulators Introduction
11.6.4 Cellectricon AB(Sweden) Revenue in Ion Channel Modulators Business (2017-2022)
11.6.5 Cellectricon AB(Sweden) Recent Development
11.7 Convergence Pharmaceuticals Limited(UK)
11.7.1 Convergence Pharmaceuticals Limited(UK) Company Detail
11.7.2 Convergence Pharmaceuticals Limited(UK) Business Overview
11.7.3 Convergence Pharmaceuticals Limited(UK) Ion Channel Modulators Introduction
11.7.4 Convergence Pharmaceuticals Limited(UK) Revenue in Ion Channel Modulators Business (2017-2022)
11.7.5 Convergence Pharmaceuticals Limited(UK) Recent Development
11.8 Cytocentrics AG(Germany)
11.8.1 Cytocentrics AG(Germany) Company Detail
11.8.2 Cytocentrics AG(Germany) Business Overview
11.8.3 Cytocentrics AG(Germany) Ion Channel Modulators Introduction
11.8.4 Cytocentrics AG(Germany) Revenue in Ion Channel Modulators Business (2017-2022)
11.8.5 Cytocentrics AG(Germany) Recent Development
11.9 Evotec AG(Germany)
11.9.1 Evotec AG(Germany) Company Detail
11.9.2 Evotec AG(Germany) Business Overview
11.9.3 Evotec AG(Germany) Ion Channel Modulators Introduction
11.9.4 Evotec AG(Germany) Revenue in Ion Channel Modulators Business (2017-2022)
11.9.5 Evotec AG(Germany) Recent Development
11.10 flyion GmbH(Germany)
11.10.1 flyion GmbH(Germany) Company Detail
11.10.2 flyion GmbH(Germany) Business Overview
11.10.3 flyion GmbH(Germany) Ion Channel Modulators Introduction
11.10.4 flyion GmbH(Germany) Revenue in Ion Channel Modulators Business (2017-2022)
11.10.5 flyion GmbH(Germany) Recent Development
11.11 GlaxoSmithKline Plc.(UK)
11.11.1 GlaxoSmithKline Plc.(UK) Company Detail
11.11.2 GlaxoSmithKline Plc.(UK) Business Overview
11.11.3 GlaxoSmithKline Plc.(UK) Ion Channel Modulators Introduction
11.11.4 GlaxoSmithKline Plc.(UK) Revenue in Ion Channel Modulators Business (2017-2022)
11.11.5 GlaxoSmithKline Plc.(UK) Recent Development
11.12 Nanion Technologies GmbH(Germany)
11.12.1 Nanion Technologies GmbH(Germany) Company Detail
11.12.2 Nanion Technologies GmbH(Germany) Business Overview
11.12.3 Nanion Technologies GmbH(Germany) Ion Channel Modulators Introduction
11.12.4 Nanion Technologies GmbH(Germany) Revenue in Ion Channel Modulators Business (2017-2022)
11.12.5 Nanion Technologies GmbH(Germany) Recent Development
11.13 NeuroSearch A/S(Denmark)
11.13.1 NeuroSearch A/S(Denmark) Company Detail
11.13.2 NeuroSearch A/S(Denmark) Business Overview
11.13.3 NeuroSearch A/S(Denmark) Ion Channel Modulators Introduction
11.13.4 NeuroSearch A/S(Denmark) Revenue in Ion Channel Modulators Business (2017-2022)
11.13.5 NeuroSearch A/S(Denmark) Recent Development
11.14 Novartis AG(Switzerland)
11.14.1 Novartis AG(Switzerland) Company Detail
11.14.2 Novartis AG(Switzerland) Business Overview
11.14.3 Novartis AG(Switzerland) Ion Channel Modulators Introduction
11.14.4 Novartis AG(Switzerland) Revenue in Ion Channel Modulators Business (2017-2022)
11.14.5 Novartis AG(Switzerland) Recent Development
11.15 Parion Sciences, Inc.(US)
11.15.1 Parion Sciences, Inc.(US) Company Detail
11.15.2 Parion Sciences, Inc.(US) Business Overview
11.15.3 Parion Sciences, Inc.(US) Ion Channel Modulators Introduction
11.15.4 Parion Sciences, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022)
11.15.5 Parion Sciences, Inc.(US) Recent Development
11.16 Sanofi(France)
11.16.1 Sanofi(France) Company Detail
11.16.2 Sanofi(France) Business Overview
11.16.3 Sanofi(France) Ion Channel Modulators Introduction
11.16.4 Sanofi(France) Revenue in Ion Channel Modulators Business (2017-2022)
11.16.5 Sanofi(France) Recent Development
11.17 Targacept, Inc.(US)
11.17.1 Targacept, Inc.(US) Company Detail
11.17.2 Targacept, Inc.(US) Business Overview
11.17.3 Targacept, Inc.(US) Ion Channel Modulators Introduction
11.17.4 Targacept, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022)
11.17.5 Targacept, Inc.(US) Recent Development
11.18 Xention Limited(UK)
11.18.1 Xention Limited(UK) Company Detail
11.18.2 Xention Limited(UK) Business Overview
11.18.3 Xention Limited(UK) Ion Channel Modulators Introduction
11.18.4 Xention Limited(UK) Revenue in Ion Channel Modulators Business (2017-2022)
11.18.5 Xention Limited(UK) Recent Development
11.19 Zalicus, Inc.(US)
11.19.1 Zalicus, Inc.(US) Company Detail
11.19.2 Zalicus, Inc.(US) Business Overview
11.19.3 Zalicus, Inc.(US) Ion Channel Modulators Introduction
11.19.4 Zalicus, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022)
11.19.5 Zalicus, Inc.(US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Ion Channel Modulators Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Channel Blockers
Table 3. Key Players of Channel Openers
Table 4. Global Ion Channel Modulators Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Ion Channel Modulators Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Ion Channel Modulators Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Ion Channel Modulators Market Share by Region (2017-2022)
Table 8. Global Ion Channel Modulators Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Ion Channel Modulators Market Share by Region (2023-2028)
Table 10. Ion Channel Modulators Market Trends
Table 11. Ion Channel Modulators Market Drivers
Table 12. Ion Channel Modulators Market Challenges
Table 13. Ion Channel Modulators Market Restraints
Table 14. Global Ion Channel Modulators Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Ion Channel Modulators Market Share by Players (2017-2022)
Table 16. Global Top Ion Channel Modulators Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ion Channel Modulators as of 2021)
Table 17. Ranking of Global Top Ion Channel Modulators Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Ion Channel Modulators Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Ion Channel Modulators Product Solution and Service
Table 21. Date of Enter into Ion Channel Modulators Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Ion Channel Modulators Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Ion Channel Modulators Revenue Market Share by Type (2017-2022)
Table 25. Global Ion Channel Modulators Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Ion Channel Modulators Revenue Market Share by Type (2023-2028)
Table 27. Global Ion Channel Modulators Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Ion Channel Modulators Revenue Market Share by Application (2017-2022)
Table 29. Global Ion Channel Modulators Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Ion Channel Modulators Revenue Market Share by Application (2023-2028)
Table 31. North America Ion Channel Modulators Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Ion Channel Modulators Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Ion Channel Modulators Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Ion Channel Modulators Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Ion Channel Modulators Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Ion Channel Modulators Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Ion Channel Modulators Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Ion Channel Modulators Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Ion Channel Modulators Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Ion Channel Modulators Market Size by Country (2023-2028) & (US$ Million)
Table 41. Pfizer, Inc.(US) Company Detail
Table 42. Pfizer, Inc.(US) Business Overview
Table 43. Pfizer, Inc.(US) Ion Channel Modulators Product
Table 44. Pfizer, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 45. Pfizer, Inc.(US) Recent Development
Table 46. Neusentis, Inc.(US) Company Detail
Table 47. Neusentis, Inc.(US) Business Overview
Table 48. Neusentis, Inc.(US) Ion Channel Modulators Product
Table 49. Neusentis, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 50. Neusentis, Inc.(US) Recent Development
Table 51. AstraZeneca(UK) Company Detail
Table 52. AstraZeneca(UK) Business Overview
Table 53. AstraZeneca(UK) Ion Channel Modulators Product
Table 54. AstraZeneca(UK) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 55. AstraZeneca(UK) Recent Development
Table 56. Aurora Biomed, Inc.(Canada) Company Detail
Table 57. Aurora Biomed, Inc.(Canada) Business Overview
Table 58. Aurora Biomed, Inc.(Canada) Ion Channel Modulators Product
Table 59. Aurora Biomed, Inc.(Canada) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 60. Aurora Biomed, Inc.(Canada) Recent Development
Table 61. CalciMedica, Inc.(US) Company Detail
Table 62. CalciMedica, Inc.(US) Business Overview
Table 63. CalciMedica, Inc.(US) Ion Channel Modulators Product
Table 64. CalciMedica, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 65. CalciMedica, Inc.(US) Recent Development
Table 66. Cellectricon AB(Sweden) Company Detail
Table 67. Cellectricon AB(Sweden) Business Overview
Table 68. Cellectricon AB(Sweden) Ion Channel Modulators Product
Table 69. Cellectricon AB(Sweden) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 70. Cellectricon AB(Sweden) Recent Development
Table 71. Convergence Pharmaceuticals Limited(UK) Company Detail
Table 72. Convergence Pharmaceuticals Limited(UK) Business Overview
Table 73. Convergence Pharmaceuticals Limited(UK) Ion Channel Modulators Product
Table 74. Convergence Pharmaceuticals Limited(UK) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 75. Convergence Pharmaceuticals Limited(UK) Recent Development
Table 76. Cytocentrics AG(Germany) Company Detail
Table 77. Cytocentrics AG(Germany) Business Overview
Table 78. Cytocentrics AG(Germany) Ion Channel Modulators Product
Table 79. Cytocentrics AG(Germany) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 80. Cytocentrics AG(Germany) Recent Development
Table 81. Evotec AG(Germany) Company Detail
Table 82. Evotec AG(Germany) Business Overview
Table 83. Evotec AG(Germany) Ion Channel Modulators Product
Table 84. Evotec AG(Germany) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 85. Evotec AG(Germany) Recent Development
Table 86. flyion GmbH(Germany) Company Detail
Table 87. flyion GmbH(Germany) Business Overview
Table 88. flyion GmbH(Germany) Ion Channel Modulators Product
Table 89. flyion GmbH(Germany) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 90. flyion GmbH(Germany) Recent Development
Table 91. GlaxoSmithKline Plc.(UK) Company Detail
Table 92. GlaxoSmithKline Plc.(UK) Business Overview
Table 93. GlaxoSmithKline Plc.(UK) Ion Channel ModulatorsProduct
Table 94. GlaxoSmithKline Plc.(UK) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 95. GlaxoSmithKline Plc.(UK) Recent Development
Table 96. Nanion Technologies GmbH(Germany) Company Detail
Table 97. Nanion Technologies GmbH(Germany) Business Overview
Table 98. Nanion Technologies GmbH(Germany) Ion Channel ModulatorsProduct
Table 99. Nanion Technologies GmbH(Germany) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 100. Nanion Technologies GmbH(Germany) Recent Development
Table 101. NeuroSearch A/S(Denmark) Company Detail
Table 102. NeuroSearch A/S(Denmark) Business Overview
Table 103. NeuroSearch A/S(Denmark) Ion Channel ModulatorsProduct
Table 104. NeuroSearch A/S(Denmark) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 105. NeuroSearch A/S(Denmark) Recent Development
Table 106. Novartis AG(Switzerland) Company Detail
Table 107. Novartis AG(Switzerland) Business Overview
Table 108. Novartis AG(Switzerland) Ion Channel ModulatorsProduct
Table 109. Novartis AG(Switzerland) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 110. Novartis AG(Switzerland) Recent Development
Table 111. Parion Sciences, Inc.(US) Company Detail
Table 112. Parion Sciences, Inc.(US) Business Overview
Table 113. Parion Sciences, Inc.(US) Ion Channel ModulatorsProduct
Table 114. Parion Sciences, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 115. Parion Sciences, Inc.(US) Recent Development
Table 116. Sanofi(France) Company Detail
Table 117. Sanofi(France) Business Overview
Table 118. Sanofi(France) Ion Channel ModulatorsProduct
Table 119. Sanofi(France) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 120. Sanofi(France) Recent Development
Table 121. Targacept, Inc.(US) Company Detail
Table 122. Targacept, Inc.(US) Business Overview
Table 123. Targacept, Inc.(US) Ion Channel ModulatorsProduct
Table 124. Targacept, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 125. Targacept, Inc.(US) Recent Development
Table 126. Xention Limited(UK) Company Detail
Table 127. Xention Limited(UK) Business Overview
Table 128. Xention Limited(UK) Ion Channel ModulatorsProduct
Table 129. Xention Limited(UK) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 130. Xention Limited(UK) Recent Development
Table 131. Zalicus, Inc.(US) Company Detail
Table 132. Zalicus, Inc.(US) Business Overview
Table 133. Zalicus, Inc.(US) Ion Channel ModulatorsProduct
Table 134. Zalicus, Inc.(US) Revenue in Ion Channel Modulators Business (2017-2022) & (US$ Million)
Table 135. Zalicus, Inc.(US) Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ion Channel Modulators Market Share by Type: 2021 VS 2028
Figure 2. Channel Blockers Features
Figure 3. Channel Openers Features
Figure 4. Global Ion Channel Modulators Market Share by Application in 2021 & 2028
Figure 5. Clinical Trials Case Studies
Figure 6. Hospital Case Studies
Figure 7. Other Case Studies
Figure 8. Ion Channel Modulators Report Years Considered
Figure 9. Global Ion Channel Modulators Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Ion Channel Modulators Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Ion Channel Modulators Market Share by Region: 2021 VS 2028
Figure 12. Global Ion Channel Modulators Market Share by Players in 2021
Figure 13. Global Top Ion Channel Modulators Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ion Channel Modulators as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Ion Channel Modulators Revenue in 2021
Figure 15. North America Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Ion Channel Modulators Market Share by Country (2017-2028)
Figure 17. United States Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Ion Channel Modulators Market Share by Country (2017-2028)
Figure 21. Germany Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Ion Channel Modulators Market Share by Region (2017-2028)
Figure 29. China Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Ion Channel Modulators Market Share by Country (2017-2028)
Figure 37. Mexico Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Ion Channel Modulators Market Share by Country (2017-2028)
Figure 41. Turkey Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Ion Channel Modulators Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Pfizer, Inc.(US) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 44. Neusentis, Inc.(US) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 45. AstraZeneca(UK) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 46. Aurora Biomed, Inc.(Canada) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 47. CalciMedica, Inc.(US) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 48. Cellectricon AB(Sweden) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 49. Convergence Pharmaceuticals Limited(UK) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 50. Cytocentrics AG(Germany) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 51. Evotec AG(Germany) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 52. flyion GmbH(Germany) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 53. GlaxoSmithKline Plc.(UK) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 54. Nanion Technologies GmbH(Germany) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 55. NeuroSearch A/S(Denmark) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 56. Novartis AG(Switzerland) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 57. Parion Sciences, Inc.(US) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 58. Sanofi(France) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 59. Targacept, Inc.(US) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 60. Xention Limited(UK) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 61. Zalicus, Inc.(US) Revenue Growth Rate in Ion Channel Modulators Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer, Inc.(US) Neusentis, Inc.(US) AstraZeneca(UK) Aurora Biomed, Inc.(Canada) CalciMedica, Inc.(US) Cellectricon AB(Sweden) Convergence Pharmaceuticals Limited(UK) Cytocentrics AG(Germany) Evotec AG(Germany) flyion GmbH(Germany) GlaxoSmithKline Plc.(UK) Nanion Technologies GmbH(Germany) NeuroSearch A/S(Denmark) Novartis AG(Switzerland) Parion Sciences, Inc.(US) Sanofi(France) Targacept, Inc.(US) Xention Limited(UK) Zalicus, Inc.(US)